WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.45 Cr | ₹-0.28 Cr | ₹-0.57 Cr | ₹-2.03 Cr | ₹-2.04 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WINDLAS BIOTECH ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-0.45 Cr |
| Mar2025 | ₹-0.28 Cr |
| Mar2024 | ₹-0.57 Cr |
| Mar2023 | ₹-2.03 Cr |
| Mar2022 | ₹-2.04 Cr |
How is Deferred Tax Assets / Liabilities of WINDLAS BIOTECH Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-0.45 Cr | Negative | |
| Mar2025 | ₹-0.28 Cr | Negative | |
| Mar2024 | ₹-0.57 Cr | Negative | |
| Mar2023 | ₹-2.03 Cr | Negative | |
| Mar2022 | ₹-2.04 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,762.1 Cr | -0.5% | -0.3% | -7.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -0.5% |
-0.3% |
-7.2% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses